Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Antibe Therapeutics Inc | ATE | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.295 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.15 - 1.23 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.295 | CAD |
Antibe Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.26M | 52.62M | - | 6.99M | -19.48M | -0.37 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Antibe Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATE Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.16 | 0.35 | 0.15 | 0.2005897 | 548,057 | 0.135 | 84.38% |
3 Months | 0.99 | 1.08 | 0.15 | 0.4405135 | 180,618 | -0.695 | -70.20% |
6 Months | 0.60 | 1.23 | 0.15 | 0.6168434 | 116,784 | -0.305 | -50.83% |
1 Year | 0.53 | 1.23 | 0.15 | 0.5972158 | 69,569 | -0.235 | -44.34% |
3 Years | 4.35 | 4.47 | 0.15 | 1.13 | 83,013 | -4.06 | -93.22% |
5 Years | 0.415 | 7.52 | 0.15 | 1.86 | 108,272 | -0.12 | -28.92% |
Antibe Therapeutics Description
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. |